Abstract
Genes encoding growth-inhibitory proteins are postulated to be candidate tumor suppressors. The identification of such proteins may benefit the early diagnosis and therapy of tumors. Here we report the cloning and functional characterization of a novel human bone marrow stromal cell (BMSC)-derived growth inhibitor (BDGI) by large scale random sequencing of a human BMSC cDNA library. Human BDGI cDNA encodes a 477-amino acid residue protein that shares high homology with rat and mouse pregnancy-induced growth inhibitors. The C-terminal of BDGI is identical to a novel human pregnancy-induced growth inhibitor, OKL38. BDGI is also closely related to many other eukaryotic proteins, which together form a novel and highly conserved family of BDGI-like proteins. BDGI overexpression inhibits the proliferation, decreases anchorage-dependent growth, and reduces migration of MCF-7 human breast cancer cells, whereas down-regulation of BDGI expression promotes the proliferation of MCF-7 and HeLa cervix epitheloid carcinoma cells. Interestingly, the inhibitory effect of BDGI on MCF-7 cells is more potent than that of OKL38. We demonstrate that BDGI induces cell cycle arrest in S phase and subsequent apoptosis of MCF-7 cells, which is likely to account for the antiproliferative effects of BDGI. This process may involve up-regulation of p27Kip1 and down-regulation of cyclin A, Bcl-2, and Bcl-xL. The inhibitory effect of BDGI on cell proliferation and the induction of apoptosis were also observed in A549 lung cancer cells but not HeLa cells. These results indicate that BDGI might be a growth inhibitor for human tumor cells, especially breast cancer cells, possibly contributing to the development of new therapeutic strategies for breast cancer.
Highlights
At the amino acid level, the C-terminal residues of the protein were identical to human OKL38, a recently identified 317-residue protein thought to play a important role in the regulation of breast epithelial cell growth and differentiation
The results revealed a close association between BMSC-derived growth inhibitor (BDGI) and rat and mouse pregnancy-induced growth inhibitors, as expected from the high sequence identity mentioned above
We examined the effects of BDGI on MCF-7 cell proliferation, since BDGI is a longer splicing variant of the pregnancyinduced growth inhibitor, OKL38, known to inhibit cell proliferation [12]. [3H]Thymidine incorporation was used to evaluate DNA synthesis consistent with proliferation of stably transfected cells
Summary
MirgBpneerDidltonahGulatiecIeflr-eedlordifkfatoTciaBegtomriouhrDompoumtimnGshwrl,adouIaoatntdhrnirneystesnoioicinicosbnotdrlsvtehetleba.oehaintelhtBbeset,aeriDiartccstsenoGoheaarbdaulraI,cerntkthOeoohecatesvihKnrhagpdeyoLehwnro.ory3eloanTtyi8xitvgdhdc.hpeeieciBsrdnl-podaeDJrhgnrsoegauoGsstprwutiemoeIeoerrnennnaiMvinsdnabewsieCldayn,pinsFlthrtwstthf-ehaoia7hbggetmtcieinahrctlaiosnaesohluwyndstJtthecttohhMolhyoauyeof--,tCrrnisFna-grdhte7oeFlriax’frlo/isvfa-cgwemetef.retiep(hob3nd5netcAd)tieg,kniti,neanmh,htntgiwehicaebohsmeinef.at(i-o9mrrTfrire)ainsh.ractd(ssiet8Mudtate)acrwe,uatiitwnmanztiinehngttmodhido(c,e6adlramfa)sirf,nlTtena.aanccaemwTltteuoisshunmidnreW,ioianengnargwgaytuamhp-niltudtioreganhetla,myrhdBn(ipw7ovrsmDe)efarhp,oaGdswrtmorimIsygdiantreimaonegwptgpmeitutghahrrrieoifynliw-iehdadtleihbrfciirftveoaolemlcrds-and redutcheastmthigisrastuiodnyowf aMsCcFo-n7dhuucmteadnnberaeralyst2c0aynecearrs acgoon.dTithioeneadgme eodfiathoef nworomrkalamnadmtmhearlyaecpkitohfelial cells, blocks cmeolltse,swthheaervpeaariolsaldibfoielwirtanyt-ioroefngduoalfataMtiosCtnFoo-r7af gBaenDdmGIHaekexeLpsariectsedsriivfofinxicpuerpltoi--for DetphNietAhaesluyiantlhthoceerslsilsstio(n6r)c.eutlTtrhuieerevdmenotroheremrraeecl eqannutdleytsrtiadenedsnftroiarfimwededmmaammmmaarryytheloid cdaractian.oTmhaecwelitlsh.dIrnatweriensgtianugtlyh,otrhse’ oinffheibr ittoorryepefla- cedtehrieveimd gargoewtihn iqnuhiebsittoior nanwdimthamthmaatrfyr-odmerived growth inhibfect of BDanGoItohnerMeCxFp-e7rcimellesnits wmiothrethpoetseanmt tehacnontdhiattioonf waitsord-reeclalitnededgebnye ftahcetoJros uexrhniabli.t Tinhheibitory effects on the prolifOarKrLes3t8.inWwSeithpdhdemarasoewniasntnrgdaatseuuttbhhsoaertqsuBsetDnaGtteIaptihnoadptutotcsheiess acoebflolMvcCeyFcisl-7esueegdrraoowteiotshnnoionf tbtrhaeefafnsetuccdtaetnhmceeoruicnseetllemsr(op8dr–ee1lt0(a1) t1ai)no.dnTshouefpspethrfeiesnsdbinrgesasitntduicmaoter cells, whidcahtaisnliokreclyotnoclaucscioounnstofforthtihseraensetiaprrcohlisfetruadtyiv. eThisthaarttigcrloewdthesicnrhiibbeitsortshheadveiscpootveenrtiyaloffoar unsoevienl strategies to Beoffcflep-cx2tL7sK.oiTpfmi1hnBeaoDbnlirGendecIhau.disTbloteihwt,cionBasrn-DpyrcreGeeogIfrcu,f.eealTascnsthtdimeooinfawtsByoitfDifuhnGcndvyIcrocatlolviwionennincuaAegpll,-lcarBhpeucgartlhour-2alloia,cfrtetasiernosarndti-zaatetibinorthehInnaiabsattitthsicegtaasrpnnofrwcueientsnrhehcnaiotbtnfiodisbttnoruoetrdaahyonse,tfrdwcgtameurnomrecewecoprrhotsrh.actenaalilnssn,mdofvimrheslaitggvirredoaewtnitothinfiiendhibbyitolrarfgoer tion and btheeenincdouncftiiromneodf ianpbopretoassitscwaenrceeralasnodobostehrevretdypesscaolef craanndcoemr bsyeqoutehnecirnigndofeapecnDdNeAntlibstruardyieosf.human bone isnulAts5i4n9dliTuchnaetgewctahitnahctdeBrrDacwGeliInlsmgbiaguuhtttnhbooetrasHgheraLovawectihenlidlnsi.chTaibtheietdoserthfroaer-t human tuemlsoerwcheellrse, efsoprepcuiabllliycabtrieoans.t cancer cells, possithmeyarprolawnsttroomreaslucbelmls i(tBtMheSCirsf)i,1nddeinsiggsnated as the BMSC-derived growth inhibitor (BDGI). The C-terminal 317 residues of BDGI are identical to a previously identified pregnancy-inbly contributing to the development of new therapeutic duced growth inhibitor, OKL38 [12, 13], which may function to strategies for breast cancer. A deeper knowledge of the genetic alteroverexpression of exogenous BDGI can suppress the growth and migration of MCF-7 human breast cancer cells, inducing cell cycle arrest and cellular apoptosis, possibly by up-regulating expression of p27Kip and down-regulating cyclin A, Bcl-2, and Bcl-xL, whereas down-regulation of BDGI expression pro-. BDGI inhibits proliferation and induces cellular apoptosis of A549 lung cancer cells, but not HeLa cells. The inhibitory effect of BDGI on MCF-7 cells is more potent than that of OKL38.
Sign-in/Register to view highlights & summary 
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
